Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
08/08/2002 | WO2001077134A3 Process for the preparation of 6-o-propargyl erythromycin derivatives |
08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
08/08/2002 | US20020107405 Such as 9-phenyl-3,6-bis(5(carbazol-3-yl)-thiophen-2-yl)-9H-carbazole; electroluminescence; high glass transition temperature |
08/08/2002 | US20020107398 Microbicides in crop protection |
08/08/2002 | US20020107392 Quinolinone derivatives |
08/08/2002 | US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
08/08/2002 | US20020107252 Novel Compounds |
08/08/2002 | DE10105313A1 Verfahren zur Herstellung von Verbindungen mit einer CF20-Brücke Process for the preparation of compounds having a bridge-CF20 |
08/08/2002 | CA2672805A1 Pyrimidine derivatives |
08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
08/08/2002 | CA2432783A1 Potassium channel inhibitors |
08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
08/07/2002 | EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain |
08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
08/07/2002 | EP1228066A2 Sulfonamide derivatives |
08/07/2002 | EP1228062A1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridines |
08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
08/07/2002 | EP1228041A2 Indole derivatives and their use as 5ht2a ligands |
08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
08/07/2002 | EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
08/07/2002 | CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents |
08/07/2002 | CN1362958A C7 carbonate substituted taxanes as antitumor agents |
08/07/2002 | CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents |
08/07/2002 | CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents |
08/07/2002 | CN1362955A C7 ester substituted taxanes as antitumor agents |
08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
08/07/2002 | CN1362876A C10 heterosubstituted acetate taxanes as antitumor agents |
08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
08/07/2002 | CN1088711C Cephem compounds and drugs containing the compounds |
08/07/2002 | CN1088705C Thienylsulfonyamino (THIO) carbonyl compounds |
08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
08/06/2002 | US6429315 Process for preparing N6-substituted adenosine derivatives |
08/06/2002 | US6429312 N-aminoalkyldibenzothiopencarboxamide receptor subtype specific ligands |
08/06/2002 | US6429222 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
08/06/2002 | CA2223237C 1-phenyl-pyrazole derivatives and their use as parasiticidal agents |
08/01/2002 | WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |
08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
08/01/2002 | WO2002059108A1 Melanocortin receptor agonists |
08/01/2002 | WO2002059106A1 Isoindole-imide compounds, compositions, and uses thereof |
08/01/2002 | WO2002059088A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
08/01/2002 | WO2002058702A1 Urotensin-ii receptor antagonists |
08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
08/01/2002 | WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
08/01/2002 | US20020103248 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
08/01/2002 | US20020103245 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
08/01/2002 | US20020103228 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
08/01/2002 | US20020103226 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
08/01/2002 | US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
08/01/2002 | US20020103205 Muscarinic antagonists |
08/01/2002 | US20020103201 Selective NPY (Y5) antagonists (triazines) |
08/01/2002 | US20020102608 Library of indolinone compounds for use in the treatment of cancer |
08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
08/01/2002 | CA2435566A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
07/31/2002 | EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials |
07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
07/31/2002 | EP1226138A1 Fab i inhibitors |
07/31/2002 | EP1226136A2 Tyrosine kinase inhibitors |
07/31/2002 | EP1225894A1 Fab i inhibitors |
07/31/2002 | EP0958290B1 1,4-dihydropyridin derivatives and their use in therapy |
07/31/2002 | EP0527801B1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
07/31/2002 | CN1361778A Substituted thiene-3-yl-sulfonyl amino (thio) carbonyl-triazolin (thi) ones |
07/31/2002 | CN1361777A Substituted phenyl uracils |
07/31/2002 | CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
07/31/2002 | CN1361770A Heteroaromatic ring compounds |
07/31/2002 | CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one |
07/31/2002 | CN1361687A Phosphate transport inhibitors |
07/31/2002 | CN1088459C 1,4-disubstituted piperazines |
07/30/2002 | US6426360 Antiarthritic agents |
07/30/2002 | US6426356 Analgesics; hypotensive agents; antidepressants |
07/30/2002 | US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
07/25/2002 | WO2002057252A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
07/25/2002 | WO2002057249A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |